Cargando…
Assessment of geographic access to monoclonal antibodies in the United States
Using spatial modeling techniques, we highlight disparities in access to monoclonal antibodies (mAbs) used to treat COVID-19 patients. Fifteen million individuals in the United States must travel over 30 min to access mAbs. Areas with lower COVID-19 vaccination rates have worse access to essential C...
Autores principales: | Rader, Benjamin, Whaley, Christopher M, Rogers, Wesley S, Brownstein, Professor John S, Cantor, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155997/ https://www.ncbi.nlm.nih.gov/pubmed/35244695 http://dx.doi.org/10.1093/jtm/taac018 |
Ejemplares similares
-
Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates
por: Rader, Benjamin, et al.
Publicado: (2020) -
1780. COVID-19 Vaccine Accessibility and Uptake among U.S. Children Aged 6 Months-4 Years and 5 Years-11 Years by Domains of Social Vulnerability
por: Khazanchi, Rohan, et al.
Publicado: (2023) -
Homicide and geographic access to gun dealers in the United States
por: Wiebe, Douglas J, et al.
Publicado: (2009) -
Emerging Socioeconomic Disparities in COVID-19 Vaccine Second-Dose Completion Rates in the United States
por: Gertz, Autumn, et al.
Publicado: (2022) -
US Health Care Workforce Changes During the First and Second Years of the COVID-19 Pandemic
por: Cantor, Jonathan, et al.
Publicado: (2022)